Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHA:688016)
China
· Delayed Price · Currency is CNY 108.83
+4.52 (4.33%)
Mar 10, 2026, 10:34 AM CST
SHA:688016 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 12,612 | 11,083 | 13,442 | 16,101 | 13,607 | 17,904 | Upgrade
|
| Market Cap Growth | -5.17% | -17.55% | -16.51% | 18.33% | -24.00% | -0.98% | Upgrade
|
| Enterprise Value | 10,513 | 8,984 | 11,002 | 15,114 | 12,630 | 16,783 | Upgrade
|
| Last Close Price | 104.31 | 91.66 | 108.07 | 124.43 | 119.20 | 155.08 | Upgrade
|
| PE Ratio | 22.43 | 19.68 | 26.77 | 32.70 | 38.13 | 56.68 | Upgrade
|
| Forward PE | 22.23 | 16.89 | 17.88 | 23.59 | 26.68 | 46.41 | Upgrade
|
| PS Ratio | 9.34 | 8.21 | 11.14 | 13.56 | 15.18 | 26.15 | Upgrade
|
| PB Ratio | 3.17 | 2.78 | 3.52 | 4.17 | 7.81 | 11.76 | Upgrade
|
| P/TBV Ratio | 4.13 | 3.63 | 4.61 | 4.43 | 9.07 | 12.62 | Upgrade
|
| P/FCF Ratio | - | - | 83.52 | 43.75 | 342.02 | 84.98 | Upgrade
|
| P/OCF Ratio | - | - | 35.98 | 28.84 | 40.77 | 59.63 | Upgrade
|
| PEG Ratio | - | 4.36 | 4.36 | 4.36 | 4.36 | 4.36 | Upgrade
|
| EV/Sales Ratio | 7.78 | 6.65 | 9.12 | 12.73 | 14.09 | 24.51 | Upgrade
|
| EV/EBITDA Ratio | 15.27 | 13.05 | 19.87 | 27.18 | 31.90 | 50.34 | Upgrade
|
| EV/EBIT Ratio | 16.08 | 13.74 | 21.19 | 28.41 | 33.84 | 52.78 | Upgrade
|
| EV/FCF Ratio | - | - | 68.36 | 41.07 | 317.48 | 79.66 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | 0.02 | 0.02 | 0.07 | 0.06 | 0.10 | 0.13 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.25 | 0.10 | 1.03 | 0.22 | Upgrade
|
| Net Debt / Equity Ratio | -0.53 | -0.53 | -0.56 | -0.76 | -0.54 | -0.79 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.09 | -3.09 | -3.85 | -5.27 | -2.36 | -3.59 | Upgrade
|
| Net Debt / FCF Ratio | - | - | -13.23 | -7.96 | -23.52 | -5.68 | Upgrade
|
| Asset Turnover | - | - | 0.28 | 0.38 | 0.48 | 0.44 | Upgrade
|
| Inventory Turnover | - | - | 1.38 | 1.56 | 1.71 | 1.63 | Upgrade
|
| Quick Ratio | - | - | 7.15 | 9.96 | 5.90 | 8.13 | Upgrade
|
| Current Ratio | - | - | 8.08 | 10.76 | 6.93 | 9.00 | Upgrade
|
| Return on Equity (ROE) | 14.43% | 14.43% | 12.82% | 17.38% | 21.57% | 22.75% | Upgrade
|
| Return on Assets (ROA) | - | - | 7.60% | 10.66% | 12.45% | 12.70% | Upgrade
|
| Return on Invested Capital (ROIC) | 30.34% | 31.75% | 29.89% | 52.08% | 56.12% | 99.66% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 13.10% | 13.50% | 20.60% | 20.00% | Upgrade
|
| Earnings Yield | 4.47% | 5.08% | 3.74% | 3.06% | 2.62% | 1.76% | Upgrade
|
| FCF Yield | - | - | 1.20% | 2.29% | 0.29% | 1.18% | Upgrade
|
| Dividend Yield | 1.54% | - | 1.86% | 1.62% | 1.29% | 0.91% | Upgrade
|
| Payout Ratio | - | - | 89.72% | 33.62% | 42.35% | 20.51% | Upgrade
|
| Buyback Yield / Dilution | 1.82% | 1.82% | -14.50% | -0.50% | -0.00% | 0.10% | Upgrade
|
| Total Shareholder Return | 3.36% | 1.82% | -12.64% | 1.12% | 1.29% | 1.00% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.